{"nct_id":"NCT03562832","title":"Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP","status":"COMPLETED","status_verified_date":"2025-01","start_date":"2018-06-20","start_date_type":"ACTUAL","primary_completion_date":"2024-04-01","primary_completion_date_type":"ACTUAL","completion_date":"2024-08-01","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ALLR"]}